San Fernando Valley Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Amgen Opens Tampa Center

Amgen Inc. is opening a 136,000-square-foot facility in Tampa, Fla., the Tampa Hillsborough Economic Development Corp. announced Wednesday.

MannKind Turns Profitable in Fourth Quarter

MannKind Corp. (MNKD) on Thursday reported fourth-quarter and full-year financial results, beating analysts’ expectations.

Northeast Valley Health Names Chief Medical Officer

Northeast Valley Health Corp. on Monday announced the appointment of its new chief medical officer, Dr. Christine Park.

Earnings: B. Riley, ImmunoCellular, Second Sight, MRV

Roundup of quarterly reports from Valley companies.

Boston Scientific Renews Valencia Lease

Boston Scientific Corp. has renewed its current lease in Valencia and extended it for 10 years with plans to add employees, according to CBRE Group Inc.

FDA Changes ImmunoCellular Study Calendar

ImmunoCellular Therapeutics Ltd. on Monday announced that the U.S. Food and Drug Administration has approved an amendment to its registration trial for a drug, temporarily sending the company’s stock up 16 percent.

Despite Reverse Split, MannKind’s Stock Drops

MannKind Corp.’s post-split stock had a difficult initial day of trading on the market Friday, closing down nearly 13 percent.

AV Hospital Selects CFO

Antelope Valley Hospital has named Colette Menzel as its new chief financial officer, the hospital announced Wednesday.

LTC Beats Estimates

Earnings and revenue for health care facility landlord LTC Properties Inc. exceeded Wall Street expectations for the fourth quarter and the full year.

MannKind Gains $16.7 Million From Building Sale

MannKind Corp. on Tuesday announced it has received the remaining $16.7 million after closing the sale of some of its former real estate at 28901-28903 N. Avenue Paine in Valencia.

Preview: Hospitals Move to Main Street

Moving clinics off hospital campuses into non-medical locations that are also prominent and convenient is a new strategy for many major health systems.

Amgen Stock Rises on Drug Application

The stock of Amgen Inc. rose more than 2 percent Wednesday following an announcement that the Thousand Oaks biotechnology firm has applied for the Food and Drug Administration’s approval to broaden the range of disease conditions that can be treated with its leukemia drug Blincyto.

Cigna Sues Anthem for Nearly $15 Billion

Health insurer Cigna Corp. on Tuesday announced it had terminated its merger agreement with Anthem Inc. and had filed a lawsuit seeking more than $13 billion in damages from the company.

Court Rejects Anthem’s Takeover of Cigna

A federal judge ruled in favor of the Justice Department in a civil antitrust lawsuit to block health insurer Anthem, Inc.’s acquisition of Cigna Corp.

Competitor to Amgen's Repatha Gets Reprieve

Amgen Inc.’s cholesterol drug Repatha will continue to have competition for the time being.